GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Diagnostic Medical Systems (LTS:0RIA) » Definitions » Net Issuance of Preferred Stock

Diagnostic Medical Systems (LTS:0RIA) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Diagnostic Medical Systems Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Diagnostic Medical Systems's net issuance of preferred for the six months ended in Jun. 2024 was €0.00 Mil. The number is 0, which means that Diagnostic Medical Systems has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Diagnostic Medical Systems's net issuance of preferred for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.


Diagnostic Medical Systems Net Issuance of Preferred Stock Historical Data

The historical data trend for Diagnostic Medical Systems's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnostic Medical Systems Net Issuance of Preferred Stock Chart

Diagnostic Medical Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Diagnostic Medical Systems Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Diagnostic Medical Systems Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diagnostic Medical Systems Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Diagnostic Medical Systems's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnostic Medical Systems Business Description

Traded in Other Exchanges
Address
9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.

Diagnostic Medical Systems Headlines

No Headlines